TY - JOUR
KW - Adult
KW - Antiviral Agents/economics/therapeutic use
KW - Coinfection
KW - Cost-Benefit Analysis/methods
KW - cost-effectiveness
KW - Female
KW - Hepatitis C
KW - Hepatitis C, Chronic/diagnosis/economics/epidemiology
KW - Humans
KW - Male
KW - Mass Screening/economics/methods
KW - Methadone maintenance therapy
KW - Methadone/economics/therapeutic use
KW - Middle Aged
KW - New York City/epidemiology
KW - Opiate Substitution Treatment/economics/methods
KW - Quality-Adjusted Life Years
KW - San Francisco/epidemiology
KW - Treatment Outcome
KW - United States/epidemiology
AU - B. R. Schackman
AU - S. Gutkind
AU - J. R. Morgan
AU - J. A. Leff
AU - C. N. Behrends
AU - K. L. Delucchi
AU - C. McKnight
AU - D. C. Perlman
AU - C. L. Masson
AU - B. P. Linas
A1 - 
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use; Financing & Sustainability
CY - Ireland
DO - 10.1016/j.drugalcdep.2017.11.031
JF - Drug and alcohol dependence
PB - Elsevier B.V
PP - Ireland
PY - 2018
SN - 1879-0046; 0376-8716
SP - 411
EP - 420
EP - 
T1 - Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs
T2 - Drug and alcohol dependence
TI - Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs
U1 - Opioids & Substance Use; Financing & Sustainability
U2 - 29477574
U3 - 10.1016/j.drugalcdep.2017.11.031
VL - 185
VO - 1879-0046; 0376-8716
Y1 - 2018
ER -